290 related articles for article (PubMed ID: 21046178)
1. The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26.
Kotsakis P; Wang Z; Collighan RJ; Griffin M
Amino Acids; 2011 Oct; 41(4):909-21. PubMed ID: 21046178
[TBL] [Abstract][Full Text] [Related]
2. Tissue transglutaminase-mediated chemoresistance in cancer cells.
Verma A; Mehta K
Drug Resist Updat; 2007; 10(4-5):144-51. PubMed ID: 17662645
[TBL] [Abstract][Full Text] [Related]
3. Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells.
Jang GY; Jeon JH; Cho SY; Shin DM; Kim CW; Jeong EM; Bae HC; Kim TW; Lee SH; Choi Y; Lee DS; Park SC; Kim IG
Oncogene; 2010 Jan; 29(3):356-67. PubMed ID: 19838207
[TBL] [Abstract][Full Text] [Related]
4. RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 α5β1 integrin co-signaling.
Wang Z; Collighan RJ; Gross SR; Danen EH; Orend G; Telci D; Griffin M
J Biol Chem; 2010 Dec; 285(51):40212-29. PubMed ID: 20929862
[TBL] [Abstract][Full Text] [Related]
5. Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells.
Herman JF; Mangala LS; Mehta K
Oncogene; 2006 May; 25(21):3049-58. PubMed ID: 16449978
[TBL] [Abstract][Full Text] [Related]
6. Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy.
Yuan L; Siegel M; Choi K; Khosla C; Miller CR; Jackson EN; Piwnica-Worms D; Rich KM
Oncogene; 2007 Apr; 26(18):2563-73. PubMed ID: 17099729
[TBL] [Abstract][Full Text] [Related]
7. Enhanced osteoblast adhesion on transglutaminase 2-crosslinked fibronectin.
Forsprecher J; Wang Z; Nelea V; Kaartinen MT
Amino Acids; 2009 Apr; 36(4):747-53. PubMed ID: 18604470
[TBL] [Abstract][Full Text] [Related]
8. Increased TG2 expression can result in induction of transforming growth factor beta1, causing increased synthesis and deposition of matrix proteins, which can be regulated by nitric oxide.
Telci D; Collighan RJ; Basaga H; Griffin M
J Biol Chem; 2009 Oct; 284(43):29547-58. PubMed ID: 19657147
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of fibronectin and tissue transglutaminase promotes cell invasion involving increased association with integrin and MMP expression in A431 cells.
Chen SH; Lin CY; Lee LT; Chang GD; Lee PP; Hung CC; Kao WT; Tsai PH; Schally AV; Hwang JJ; Lee MT
Anticancer Res; 2010 Oct; 30(10):4177-86. PubMed ID: 21036738
[TBL] [Abstract][Full Text] [Related]
10. Transglutaminase 2 and NF-kappaB interplay during NGF-induced differentiation of neuroblastoma cells.
Condello S; Caccamo D; Currò M; Ferlazzo N; Parisi G; Ientile R
Brain Res; 2008 May; 1207():1-8. PubMed ID: 18374307
[TBL] [Abstract][Full Text] [Related]
11. The integrin alpha5beta1 regulates chondrocyte hypertrophic differentiation induced by GTP-bound transglutaminase 2.
Tanaka K; Yokosaki Y; Higashikawa F; Saito Y; Eboshida A; Ochi M
Matrix Biol; 2007 Jul; 26(6):409-18. PubMed ID: 17490870
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of transglutaminase 2 (TG2) at serine-216 has a role in TG2 mediated activation of nuclear factor-kappa B and in the downregulation of PTEN.
Wang Y; Ande SR; Mishra S
BMC Cancer; 2012 Jul; 12():277. PubMed ID: 22759359
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer.
Mehta K; Fok J; Miller FR; Koul D; Sahin AA
Clin Cancer Res; 2004 Dec; 10(23):8068-76. PubMed ID: 15585642
[TBL] [Abstract][Full Text] [Related]
14. Tissue transglutaminase in tumour progression: friend or foe?
Kotsakis P; Griffin M
Amino Acids; 2007 Aug; 33(2):373-84. PubMed ID: 17581697
[TBL] [Abstract][Full Text] [Related]
15. Extracellular tissue transglutaminase activates noncanonical NF-κB signaling and promotes metastasis in ovarian cancer.
Yakubov B; Chelladurai B; Schmitt J; Emerson R; Turchi JJ; Matei D
Neoplasia; 2013 Jun; 15(6):609-19. PubMed ID: 23730209
[TBL] [Abstract][Full Text] [Related]
16. Transglutaminase 2 limits murine peritoneal acute gout-like inflammation by regulating macrophage clearance of apoptotic neutrophils.
Rose DM; Sydlaske AD; Agha-Babakhani A; Johnson K; Terkeltaub R
Arthritis Rheum; 2006 Oct; 54(10):3363-71. PubMed ID: 17009310
[TBL] [Abstract][Full Text] [Related]
17. Transglutaminase 2 silencing reduced the beta-amyloid-effects on the activation of human THP-1 cells.
Currò M; Ferlazzo N; Condello S; Caccamo D; Ientile R
Amino Acids; 2010 Nov; 39(5):1427-33. PubMed ID: 20437185
[TBL] [Abstract][Full Text] [Related]
18. Tissue transglutaminase induces Epithelial-Mesenchymal-Transition and the acquisition of stem cell like characteristics in colorectal cancer cells.
Ayinde O; Wang Z; Griffin M
Oncotarget; 2017 Mar; 8(12):20025-20041. PubMed ID: 28223538
[TBL] [Abstract][Full Text] [Related]
19. Tissue transglutaminase (TG2) acting as G protein protects hepatocytes against Fas-mediated cell death in mice.
Sarang Z; Molnár P; Németh T; Gomba S; Kardon T; Melino G; Cotecchia S; Fésüs L; Szondy Z
Hepatology; 2005 Sep; 42(3):578-87. PubMed ID: 16108039
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in understanding the roles of transglutaminase 2 in alcoholic steatohepatitis.
Tatsukawa H; Kojima S
Cell Biol Int; 2010 Feb; 34(3):325-34. PubMed ID: 20192918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
